Attached files
| file | filename |
|---|---|
| S-1/A - AMENDMENT NO. 1 TO FORM S-1 - Audentes Therapeutics, Inc. | d892618ds1a.htm |
| EX-10.9 - OFFICE LEASE - Audentes Therapeutics, Inc. | d892618dex109.htm |
| EX-4.1 - FORM OF COMMON STOCK CERTIFICATE - Audentes Therapeutics, Inc. | d892618dex41.htm |
| EX-10.8 - FORM OF BOARD MEMBER OFFER LETTER - Audentes Therapeutics, Inc. | d892618dex108.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
Audentes Therapeutics, Inc.:
We consent to the use of our report included herein and to the reference to our firm under the heading “Experts” in the prospectus.
/s/ KPMG LLP
San Francisco, California
March 9, 2016